Role of the RARRES1 gene in nasopharyngeal carcinoma

Cancer Genetics and Cytogenetics

Volumn 194, Issue 1, 2009, Pages 58-64

  Kwok, Wai Kei ^a,b   Pang, Jesse Chung Sean ^a,b   Lo, Kwok Wai ^a,b   Ng, Ho Keung ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; GENOMIC DNA; RETINOIC ACID RECEPTOR RESPONDER 1; RETINOID; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; VIRUS INFECTION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

ALIAS; HUMAN HERPESVIRUS 4;

EID: 69549088103     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.005     Document Type: Article

References (36)

1. Huang D.P., and Lo K.W. Aetiological factors and pathogenesis. In: van Hasselt C.A., and Gibb A.G. (Eds). Nasopharyngeal carcinoma. 2nd ed (1999), Chinese University Press, Hong Kong 31-60
2. Hong Kong Cancer Registry, Hospital Authority. Hong Kong Cancer Stat 2006 [Internet]. Version 1. December 2008. Available at: http://www3.ha.org.hk/cancereg/e_canstat2006.pdf.
3. Lo K.W., To K.F., and Huang D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 5 (2004) 423-428
4. Lo K.W., Cheung S.T., Leung S.F., van Hasselt A., Tsang Y.S., Mak K.F., Chung Y.F., Woo J.K., Lee J.C., and Huang D.P. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56 (1996) 2721-2725
5. Lo K.W., Kwong J., Hui A.B., Chan S.Y., To K.F., Chan A.S., Chow L.S., Teo P.M., Johnson P.J., and Huang D.P. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61 (2001) 3877-3881
6. Kwong J., Lo K.W., To K.F., Teo P.M., Johnson P.J., and Huang D.P. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8 (2002) 131-137
7. Kwong J., Chow L.S., Wong A.Y., Hung W.K., Chung G.T., To K.F., Chan F.L., Daigo Y., Nakamura Y., Huang D.P., and Lo K.W. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 46 (2007) 171-180
8. Blomhoff R., and Blomhoff H.K. Overview of retinoid metabolism and function. J Neurobiol 66 (2006) 606-630
9. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808
10. Scaglioni P.P., and Pandolfi P.P. The theory of APL revisited. Curr Top Microbiol Immunol 313 (2007) 85-100
11. Lam P.K., To E.W., Chan E.S., Liew C.T., Lung I.W., and King W.K. In vitro inhibition of head and neck cancer-cell growth by human recombinant interferon-alpha and 13-cis retinoic acid. Br J Biomed Sci 58 (2001) 226-229
12. Kwong J., Lo K.W., Chow L.S., To K.F., Choy K.W., Chan F.L., Mok S.C., and Huang D.P. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia 7 (2005) 67-74
13. Kwong J., Lo K.W., Chow L.S., Chan F.L., To K.F., and Huang D.P. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer 113 (2005) 386-392
14. Nagpal S., Patel S., Asano A.T., Johnson A.T., Duvic M., and Chandraratna R.A. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-response gene in skin. J Invest Dermatol 106 (1996) 269-274
15. Jing C., El-Ghany M.A., Beesley C., Foster C.S., Rudland P.S., Smith P., and Ke Y. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 94 (2002) 482-490
16. Zhang J., Liu L., and Pfeifer G.P. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Oncogene 23 (2004) 2241-2249
17. Cho N.Y., Kim B.H., Choi M., Yoo E.J., Moon K.C., Cho Y.M., Kim D., and Kang G.H. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 211 (2007) 269-277
18. Youssef E.M., Chen X.Q., Higuchi E., Kondo Y., Garcia-Manero G., Lotan R., and Issa J.P. Hypermethylation and silencing of the putative tumor suppressor tazarotene-induced gene 1 in human cancers. Cancer Res 64 (2004) 2411-2417
19. Takai N., Kawamata N., Walsh C.S., Gery S., Desmond J.C., Whittaker S., Said J.W., Popoviciu L.M., Jones P.A., Miyakawa I., and Koeffler H.P. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol Cancer Res 3 (2005) 261-269
20. Shutoh M., Oue N., Aung P.P., Noguchi T., Kuraoka K., Nakayama H., Kawahara K., and Yasui W. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer 104 (2005) 1609-1619
21. Mizuiri H., Yoshida K., Toge T., Oue N., Aung P.P., Noguchi T., and Yasui W. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci 96 (2005) 571-577
22. Kim B.H., Cho N.Y., Choi M., Lee S., Jang J.J., and Kang G.H. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas. Arch Pathol Lab Med 131 (2007) 923-930
23. Ellinger J., El Kassem N., Heukamp L.C., Matthews S., Cubukluoz F., Kahl P., Perabo F.G., Müller S.C., von Ruecker A., and Bastian P.J. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. J Urol 179 (2008) 346-352
24. Jeronimo C., Monteiro P., Henrique R., Dinis-Ribeiro M., Costa I., Costa V.L., Filipe L., Carvalho A.L., Hoque M.O., Pais I., Leal C., Teixeira M.R., and Sidransky D. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. Breast Cancer Res Treat 109 (2008) 27-34
25. Yanatatsaneejit P., Chalermchai T., Kerekhanjanarong V., Shotelersuk K., Supiyaphun P., Mutirangura A., and Sriuranpong V. Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. Oral Oncol 44 (2008) 400-406
26. Bonazzi V.F., Irwin D., and Hayward N.K. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 48 (2009) 10-21
27. Wu C.C., Shyu R.Y., Chou J.M., Jao S.W., Chao P.C., Kang J.C., Wu S.T., Huang S.L., and Jiang S.Y. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer 42 (2006) 557-565
28. Lo A.K., Lo K.W., Tsao S.W., Wong H.L., Hui J.W., To K.F., Hayward D.S., Chui Y.L., Lau Y.L., Takada K., and Huang D.P. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8 (2006) 173-180
29. ARF in TWIST-mediated senescence in prostate epithelial cells. Carcinogenesis 28 (2007) 2467-2475
30. Kwok W.K., Ling M.T., Lee T.W., Lau T.C., Zhou C., Zhang X., Chua C.W., Chan K.W., Chan F.L., Glackin C., Wong Y.C., and Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65 (2005) 5153-5162
31. Shen H.M., and Tergaonkar V. NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 14 (2009) 348-363
32. Lo A.K., Liu Y., Wang X.H., Huang D.P., Yuen P.W., Wong Y.C., and Tsao G.S. Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83 (2003) 697-709
33. Kondo S., Yoshizaki T., Wakisaka N., Horikawa T., Murono S., Jang K.L., Joab I., Furukawa M., and Pagano J.S. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol 81 (2007) 1554-1562
34. Dawson C.W., Laverick L., Morris M.A., Tramoutanis G., and Young L.S. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 82 (2008) 3654-3664
35. Endo K., Kondo S., Shackleford J., Horikawa T., Kitagawa N., Yoshizaki T., Furukawa M., Zen Y., and Pagano J.S. Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene 28 (2009) 1725-1735
36. Pegtel D.M., Subramanian A., Sheen T.S., Tsai C.H., Golub T.R., and Thorley-Lawson D.A. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 79 (2005) 15430-15442